Percheron Therapeutics Limited has released a press release.
Quarterly Activities Report and Appendix 4C
Earlier from Percheron Therapeutics
- Percheron Therapeutics Limited to Present at the Life Sciences Virtual Investor Forum September 18th
- Appendix 4E and Annual Report
- Percheron licenses HMBD-002 from Hummingbird Bioscience